Genome Edited iPSCs (KO) PARK2-/-, Parkinson's Disease (PD), Biallelic KO *Academic Price

Reference the resources below for more information about the product/service or contact us today to learn more.
SKU :
ASE-9400ASC
Catalog # :
ASE-9400ASC
Size :
1 vial (1 x 10^6)
$10,000.00
-
+
  • Description
  • Related Products

* Price listed above is for academic institutions for research purposes only

MTA is required

BUTTON-download-mta

Applied StemCell's Genome Edited series of iPSC lines are ideal as in vitro models for neurodegenerative diseases such as Parkinson’s Disease, Alzheimer’s Disease, ALS, Autism and more. The ASE-9400ASC iPSC line is engineered with a bi-allelic (homozygous) knockout for PARK2 gene (PARK2-/-) that has been implicated in familial etiology of Parkinson’s disease. The parental iPSC is ASE-9211 which is an integration-free, normal karyotype iPSC derived from male fibroblasts. The PARK2 knockout line can be further differentiated into an isogenic panel of neurons and glia for disease modeling and drug/ toxicity screening applications.

Google